1. Home
  2. Analysis
  3. Zolpidem
  4. Basaglar

Zolpidem and Basaglar drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zolpidem (zolpidem tartrate) and Basaglar (insulin glargine). Common drug interactions include back pain among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Zolpidem and Basaglar. It is created by eHealthMe based on reports of 50 people who take the same drugs from the FDA, and is updated regularly.

What is Zolpidem?

Zolpidem has active ingredients of zolpidem tartrate. It is often used in insomnia. eHealthMe is studying from 92,695 Zolpidem users. Check the latest studies of Zolpidem.

What is Basaglar?

Basaglar has active ingredients of insulin glargine. eHealthMe is studying from 19,807 Basaglar users. Check the latest studies of Basaglar.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 29, 2026

50 people who take Zolpidem and Basaglar together, and have interactions are studied.

Zolpidem and Basaglar drug interactions.

What are the common drug interactions of Zolpidem and Basaglar, by gender? *:

female:

  1. Back pain
  2. Cellulitis (infection under the skin)
  3. Cellulitis gangrenous (localized inflammation of the soft or connective tissue with considerable mass of body tissue dies (necrosis))
  4. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  5. Chest pain
  6. Crying
  7. Dizziness
  8. Dyspnoea (difficult or laboured respiration)
  9. Erythema (redness of the skin)
  10. Feeling hot

male:

  1. Anxiety
  2. Fatigue (feeling of tiredness)
  3. Chest discomfort
  4. Crepitations (noises are produced by the rubbing of parts one against the other)
  5. Dissociation
  6. Dizziness
  7. Dyskinesia (abnormality or impairment of voluntary movement)
  8. Emotional distress
  9. Eye pain
  10. Fall

What are the common drug interactions of Zolpidem and Basaglar, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Chronic kidney disease
  2. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  3. Nephrogenic anaemia (anaemia due to kidney disease)
  4. Renal failure (kidney dysfunction)
  5. Renal tubular necrosis (death of kidney tubules)

40-49:

  1. Pain
  2. Rib fracture
  3. Wrist fracture
  4. Drug ineffective
  5. Fear
  6. Anaemia (lack of blood)
  7. Haemorrhage (bleeding)
  8. Hypoglycaemia (deficiency of glucose in the bloodstream)
  9. Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
  10. Anhedonia (inability to experience pleasure from activities usually found enjoyable)

50-59:

  1. Dizziness
  2. Nausea (feeling of having an urge to vomit)
  3. Asthenia (weakness)
  4. Balance disorder
  5. Chest discomfort
  6. Dissociation
  7. Dyskinesia (abnormality or impairment of voluntary movement)
  8. Fall
  9. Headache (pain in head)
  10. Ill-defined disorder

60+:

  1. Renal failure (kidney dysfunction)
  2. Chronic kidney disease
  3. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  4. Cough
  5. Drug ineffective
  6. Glycosylated haemoglobin increased
  7. Injection site bruising
  8. Nausea (feeling of having an urge to vomit)
  9. Neoplasm (tumour)
  10. Pain

What are the existing conditions these people have? *

  1. High Blood Pressure: 9 people, 18.00%
  2. Immunodeficiency Common Variable: 6 people, 12.00%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 12.00%
  4. Diabetes: 6 people, 12.00%
  5. Type 2 Diabetes: 5 people, 10.00%
  6. Pain: 5 people, 10.00%
  7. Multiple Myeloma (cancer of the plasma cells): 4 people, 8.00%
  8. High Blood Cholesterol: 4 people, 8.00%
  9. Depression: 4 people, 8.00%
  10. Thyroid Diseases: 3 people, 6.00%

* Approximation only. Some reports may have incomplete information.

Do you take Zolpidem and Basaglar?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Zolpidem and Basaglar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Zolpidem:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Basaglar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zolpidem and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Basaglar and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on zolpidem tartrate and insulin glargine (the active ingredients of Zolpidem and Basaglar, respectively), and Zolpidem and Basaglar (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.